Search results

(1 - 5 of 5)

Hassan, S.; Cannavo, A.; Gouw, S.C.; Rosendaal, F.R.; Bom, J.G. van der 2018

Factor VIII products and inhibitor development in previously treated patients with severe or moderately severe hemophilia A: a systematic review

Article / Letter to editor

open access

Spena, S.; Garagiola, I.; Cannavo, A.; Mortarino, M.; Mannucci, P.M.; Rosendaal, F.R.; ... ; SIPPET Study Grp 2018

Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement

Article / Letter to editor

metadata only

Fasulo, M.R.; Biguzzi, E.; Abbattista, M.; Stufano, F.; Pagliari, M.T.; Mancini, I.; ... ; Rosendaal, F.R. 2018

The ISTH Bleeding Assessment Tool and the risk of future bleeding

Article / Letter to editor

metadata only

Peyvandi, F.; Cannavo, A.; Garagiola, I.; Palla, R.; Mannucci, P.M.; Rosendaal, F.R.; Sippet Study Grp 2018

Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis

Article / Letter to editor

metadata only

Cannavo, A.; Valsecchi, C.; Garagiola, I.; Palla, R.; Mannucci, P.M.; Rosendaal, F.R.; Peyvandi, F. 2017

Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A

Article / Letter to editor

metadata only

Leiden University Scholarly Publications